The Innovative Medicines Initiative: A European Response to the Innovation Challenge

E-ISSN： 1532-6535|91|3|418-425

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.91, Iss.3, 2012-03, pp. : 418-425

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 181, Iss. 3, 2015-09 ,pp. : 385-400

John Wiley & Sons Inc

Access to resources Recommend Favorite

Accelerated Access to Innovative Medicines for Patients in Need

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 5, 2014-11 ,pp. : 559-571

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Pathway for the Future: An Update on NINR's Innovative Questions Initiative

JOURNAL OF NURSING SCHOLARSHIP, Vol. 47, Iss. 2, 2015-03 ,pp. : 105-105

John Wiley & Sons Inc

Access to resources Recommend Favorite

Misuse of Medicines in the European Union: A Systematic Review of the Literature

European Addiction Research, Vol. 18, Iss. 5, 2012-05 ,pp. : 228-245

Karger

Access to resources Recommend Favorite

European regulatory perspectives for innovative therapies

By Ormarsdottir S. Reginster J.-Y. Abadie E.

Osteoporosis International, Vol. 19, Iss. 6, 2008-06 ,pp. : 725-731

Springer Publishing Company

Access to resources Recommend Favorite